Company: DVAX
Filing Date: 2025-02-20
Form Type: DEFA14A
Source: 0001193125-25-029819
Chunk: 7

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-02-20
Form: DEFA14A
Chunk 7
---
itation of proxies for the 2025 Annual Meeting. Information about Dynavax’s directors and executive officers , including their respective direct or indirect interests, by security holdings or otherwise, is available in the Company’s
proxy statement on Schedule 14A for its 2024 annual meeting of stockholders, filed with the SEC on April 11, 2024
(availablehere). To the extent holdings of Dynavax securities reported in the proxy statement have changed, such changes have been or will
be reflected on Statements of Change in Ownership on Forms 3, 4 or 5 filed with the SEC. Updated information regarding the identity of potential participants and their direct or indirect interests, by security holdings or otherwise, will be set
forth in the Company’s proxy statement for the 2025 Annual Meeting and other relevant documents filed with the SEC in connection with the 2025 Annual Meeting when they become available. These documents are or, when they become available, will
be available free of charge at the SEC’s website at .

For Investors:

Paul Cox

510-665-0499

or

MacKenzie Partners, Inc.

Bob Marese/John Bryan

Toll-Free:
1-800-322-2885

Email:

For Media:

Collected Strategies

Dan Moore / Tali Epstein

Page5of5